Quote:
Originally Posted by Altavia
Emergency Use Authorization Vs. Full FDA Approval: What’s the Difference? > News > Yale Medicine.
" How does the EUA process differ from the full FDA approval process?
Amid the myriad paperwork/administrative differences between the two options (more detail below), there are two standout differences—and they have nothing to do with the scientific rigor of the trials.
For an EUA for a COVID-19 vaccine, for example, the FDA requires that at least half of the clinical trial participants be followed for at least two months after vaccination. For full FDA approval of a COVID-19 vaccine, participants are followed for at least six months.
The full approval requires more data about the vaccine-maker’s processes and facilities, including inspections of manufacturing plants. "
|
Last time I checked, 6>2...
And the new vaccine booster? No human testing...